1887

Abstract

Pneumonia is highly prevalent in intensive care units (ICUs), with high associated mortality. Empirical treatment prioritizes breadth of coverage while awaiting laboratory diagnosis, often at the expense of antimicrobial stewardship. Microarrays use multiple parallel polymerase chain reactions to enable a rapid syndromic approach to laboratory diagnosis.

To evaluate the clinical and laboratory implications of introducing a bespoke 22-pathogen TaqMan Array Card (TAC) for rapid pathogen detection in deep respiratory samples from adult ICUs.

TAC results from all ICU patients prospectively tested over a 9-month period at Cambridge’s Clinical Microbiology and Public Health Laboratory were compared to those of corresponding conventional microbiological assays (culture-, PCR- or serology-based) in terms of result agreement and time-to-result availability. Clinical impact was assessed by retrospective review of medical records.

Seventy-one patients were included [45 (63 %) male, median age 59). Overall result agreement was 94 %, with TAC detecting more pathogens than conventional methods. TAC detected more readily than culture (7 vs 0 cases; =0.02). TAC did not detect spp. in eight culture- or galactomannan-positive cases. The median turnaround time (1 day) was significantly shorter than that of bacterial/fungal culture, PCR and galactomannan testing (each 3 days; <0.001), atypical bacteria serology (13 days; <0.001) and culture (46 days; <0.001). Earlier result availability prompted discontinuation of unnecessary antimicrobials in 15/71 (21 %) cases, but had no bearing on patient isolation/deisolation.

TAC provided greater overall yield of pathogen detection and faster turnaround times, permitting earlier discontinuation of unnecessary antimicrobials.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001218
2020-06-18
2020-08-11
Loading full text...

Full text loading...

/deliver/fulltext/jmm/69/7/971.html?itemId=/content/journal/jmm/10.1099/jmm.0.001218&mimeType=html&fmt=ahah

References

  1. Key statistics from the Case Mix Programme - Adult, General Critical Care Units London: intensive care national audit research centre; 2018p. 7
  2. Morris AC, Hay AW, Swann DG, Everingham K, McCulloch C et al. Reducing ventilator-associated pneumonia in intensive care: impact of implementing a care bundle. Crit Care Med 2011; 39:2218–2224 [CrossRef][PubMed]
    [Google Scholar]
  3. Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014; 42:1749–1755 [CrossRef][PubMed]
    [Google Scholar]
  4. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43:304–377 [CrossRef][PubMed]
    [Google Scholar]
  5. Rello J. Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia. European Respiratory Review 2007; 16:33–39 [CrossRef]
    [Google Scholar]
  6. Lee JS, Giesler DL, Gellad WF, Fine MJ. Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review. JAMA 2016; 315:593–602 [CrossRef][PubMed]
    [Google Scholar]
  7. Miller MB, Tang Y-W. Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev 2009; 22:611–633 [CrossRef][PubMed]
    [Google Scholar]
  8. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996; 14:457–460 [CrossRef][PubMed]
    [Google Scholar]
  9. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403:503–511 [CrossRef][PubMed]
    [Google Scholar]
  10. Kim I-J, Kang HC, Park J-G. Microarray applications in cancer research. Cancer Res Treat 2004; 36:207–213 [CrossRef][PubMed]
    [Google Scholar]
  11. Kumar R, Sharma A, Tiwari RK. Application of microarray in breast cancer: an overview. J Pharm Bioallied Sci 2012; 4:21–26 [CrossRef][PubMed]
    [Google Scholar]
  12. Manning M, Hudgins L, PPaG C. Professional Practice and Guidelines Committee Array-Based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010; 12:742–745 [CrossRef][PubMed]
    [Google Scholar]
  13. Henderson LB, Applegate CD, Wohler E, Sheridan MB, Hoover-Fong J et al. The impact of chromosomal microarray on clinical management: a retrospective analysis. Genet Med 2014; 16:657–664 [CrossRef][PubMed]
    [Google Scholar]
  14. Bryant PA, Venter D, Robins-Browne R, Curtis N. Chips with everything: DNA microarrays in infectious diseases. Lancet Infect Dis 2004; 4:100–111 [CrossRef][PubMed]
    [Google Scholar]
  15. Chen T. DNA microarrays--an armory for combating infectious diseases in the new century. Infect Disord Drug Targets 2006; 6:263–279 [CrossRef][PubMed]
    [Google Scholar]
  16. Donatin E, Drancourt M. DNA microarrays for the diagnosis of infectious diseases. Med Mal Infect 2012; 42:453–459 [CrossRef][PubMed]
    [Google Scholar]
  17. Xu X, Yuan B, Liang Q, Huang H, Yin X et al. Gene expression profile analysis of ventilator-associated pneumonia. Mol Med Rep 2015; 12:7455–7462 [CrossRef][PubMed]
    [Google Scholar]
  18. Kulohoma BW, Marriage F, Vasieva O, Mankhambo L, Nguyen K et al. Peripheral blood RNA gene expression in children with pneumococcal meningitis: a prospective case-control study. BMJ Paediatr Open 2017; 1:e000092 [CrossRef][PubMed]
    [Google Scholar]
  19. Severino P, Silva E, Baggio-Zappia GL, Brunialti MKC, Nucci LA et al. Gene expression profiling of mononuclear cells from patients with sepsis secondary to community-acquired pneumonia. Genom Data 2014; 2:332–334 [CrossRef][PubMed]
    [Google Scholar]
  20. Kodani M, Yang G, Conklin LM, Travis TC, Whitney CG et al. Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol 2011; 49:2175–2182 [CrossRef][PubMed]
    [Google Scholar]
  21. Weinberg GA, Schnabel KC, Erdman DD, Prill MM, Iwane MK et al. Field evaluation of TaqMan array card (Tac) for the simultaneous detection of multiple respiratory viruses in children with acute respiratory infection. J Clin Virol 2013; 57:254–260 [CrossRef][PubMed]
    [Google Scholar]
  22. Roth SB, Jalava J, Ruuskanen O, Ruohola A, Nikkari S. Use of an oligonucleotide array for laboratory diagnosis of bacteria responsible for acute upper respiratory infections. J Clin Microbiol 2004; 42:4268–4274 [CrossRef][PubMed]
    [Google Scholar]
  23. Cannon GA, Carr MJ, Yandle Z, Schaffer K, Kidney R et al. A low density oligonucleotide microarray for the detection of viral and atypical bacterial respiratory pathogens. J Virol Methods 2010; 163:17–24 [CrossRef][PubMed]
    [Google Scholar]
  24. Zimenkov DV, Kulagina EV, Antonova OV, Krasnova MA, Chernyaeva EN et al. Evaluation of a low-density hydrogel microarray technique for mycobacterial species identification. J Clin Microbiol 2015; 53:1103–1114 [CrossRef][PubMed]
    [Google Scholar]
  25. Kim CM, Song ES, Jang HJ, Kim H-J, Lee S et al. Development and evaluation of oligonucleotide chip based on the 16S-23S rRNA gene spacer region for detection of pathogenic microorganisms associated with sepsis. J Clin Microbiol 2010; 48:1578–1583 [CrossRef][PubMed]
    [Google Scholar]
  26. Steensels D, Reynders M, Descheemaeker P, Curran MD, Jacobs F et al. Clinical evaluation of a multi-parameter customized respiratory TaqMan(®) array card compared to conventional methods in immunocompromised patients. J Clin Virol 2015; 72:36–41 [CrossRef][PubMed]
    [Google Scholar]
  27. Sakai T, Kohzaki K, Watanabe A, Tsuneoka H, Shimadzu M. Use of DNA microarray analysis in diagnosis of bacterial and fungal endophthalmitis. Clin Ophthalmol 2012; 6:321–326 [CrossRef][PubMed]
    [Google Scholar]
  28. Tokman HB, Aslan M, Ortaköylü G, Algingil RC, Yüksel P et al. Microorganisms in respiratory tract of patients diagnosed with atypical pneumonia: results of a research based on the use of reverse transcription polymerase chain reaction (RT-PCR) DNA microarray method and enzyme-linked immunosorbent assay. Clin Lab 2014; 60:1027–1034 [CrossRef][PubMed]
    [Google Scholar]
  29. Cao J, Gao S, Chen J, Zhu B, Min R et al. The preparation and clinical application of diagnostic DNA microarray for the detection of pathogens in intracranial bacterial and fungal infections. Exp Ther Med 2018; 16:1304–1310 [CrossRef][PubMed]
    [Google Scholar]
  30. Ozongwu C, Personne Y, Platt G, Jeanes C, Aydin S et al. The Unyvero P55 'sample-in, answer-out' pneumonia assay: A performance evaluation. Biomol Detect Quantif 2017; 13:1–6 [CrossRef][PubMed]
    [Google Scholar]
  31. Papan C, Meyer-Buehn M, Laniado G, Nicolai T, Griese M et al. Assessment of the multiplex PCR-based assay Unyvero pneumonia application for detection of bacterial pathogens and antibiotic resistance genes in children and neonates. Infection 2018; 46:189–196 [CrossRef][PubMed]
    [Google Scholar]
  32. Jahn K, Kuisma M, Mäki M, Grendelmeier P, Hirsch HH et al. Molecular diagnostics for bacterial infections in bronchoalveolar lavage-a case-control, pilot study. Swiss Med Wkly 2015; 145:w14193 [CrossRef][PubMed]
    [Google Scholar]
  33. Applied Biosystems Taqman array cards product Bulletin; 2015
  34. Murdoch DR, Anderson TP, Beynon KA, Chua A, Fleming AM et al. Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol 2003; 41:63–66 [CrossRef][PubMed]
    [Google Scholar]
  35. Torres A, Lee N, Cilloniz C, Vila J, Van der Eerden M. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J 2016; 48:1764–1778 [CrossRef][PubMed]
    [Google Scholar]
  36. Garin N, Genné D, Carballo S, Chuard C, Eich G et al. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med 2014; 174:1894–1901 [CrossRef][PubMed]
    [Google Scholar]
  37. Patel R, Fang FC. Diagnostic stewardship: opportunity for a Laboratory-Infectious diseases partnership. Clin Infect Dis 2018; 67:799–801 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001218
Loading
/content/journal/jmm/10.1099/jmm.0.001218
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error